康臣药业(01681)11月5日耗资约298.23万港元回购20万股

Core Viewpoint - 康臣药业 announced a share buyback plan, intending to repurchase 200,000 shares at a cost of approximately HKD 2.9823 million on November 5, 2025 [1] Company Summary - 康臣药业 plans to execute a share buyback, which may indicate confidence in its financial position and a strategy to enhance shareholder value [1]